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Edited by Gianni CesareniAbstract The suppressor of cytokine signaling (SOCS) pro-
teins are thought to exert their function through the recruitment
of interacting-proteins to the ubiquitin/proteasome degradation
pathway. All SOCS proteins bind an Elongin BC E3 ubiquitin
ligase complex through the common Socs-box. Here, we show
that haem-oxidized IRP2 ubiquitin ligase-1 (HOIL-1), another
E3 ubiquitin ligase, interacts with SOCS6. The Ubl domain of
HOIL-1 and the SH2 and Socs-box domains of SOCS6 are re-
quired for the interaction. HOIL-1 expression stabilizes SOCS6
and induces the ubiquitination and degradation of proteins asso-
ciated with SOCS6. These data suggest that SOCS proteins
may interact with diﬀerent E3 ubiquitin ligases in addition to a
common Elongin BC E3 complex.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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UIP281. Introduction
The suppressor of cytokine signaling (SOCS) proteins are a
family of eight adaptors involved in the negative regulation of
cytokine signalling. CIS, SOCS1, 2 and 3 have been extensively
studied. These proteins act as negative feedback regulators of
‘‘classical’’ cytokine receptors, through inhibition of the janus
kinase/signal transducer and activator of transcription (Jak/
STAT) pathway [1–3]. Recently, SOCS proteins have been
shown to play a role in the negative regulation of receptor
tyrosine kinase signaling such as IGF-1R [4,5], insulin receptor
(IR) [6,7], EGFR [8,9] and KIT [10,11].
Mice lacking SOCS6 develop normally but show a 10%
reduction in weight at ﬁve weeks of age compared to wild-type
littermates [12]. SOCS6 interacts with IRS-2, IRS-4 and the
p85 subunit of phosphatidylinositol 3-kinase [12] and impairs
IR signaling [13]. We have recently shown that SOCS6 protein
interacts with KIT receptor following Stem Cell Factor stimu-
lation [11]. Ectopic expression of SOCS6 negatively regulates
KIT receptor-mediated proliferation and reduces activation
of the ERK and p38 MAPK pathways. Unlike other SOCS
family members, SOCS6 does not inhibit signaling by growth
hormone, leukaemia inhibitory factor or prolactin [14,15].*Corresponding author. Fax: +33 491 260 364.
E-mail address: sepulveda@marseille.inserm.fr (P. De Sepulveda).
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doi:10.1016/j.febslet.2006.03.093The Elongin BC complex associates with members of the
Cullin family and with the RING-ﬁnger protein Rbx1 to
form a multi-protein complex with E3 ubiquitin ligase activ-
ity. Binding of Elongin C to the Socs-box domain suggested
that SOCS proteins are connected to an E3 ubiquitin-ligase
complex [16]. Various studies have demonstrated that
SOCS1 and SOCS3 proteins target their partners for ubiqui-
tination and subsequently for proteasome-mediated degrada-
tion. This has been shown for the SOCS1 interactors Jak2
[17], TEL-JAK2 [18,19], VAV [20], IRS1 [21] and p65 with
SOCS1 [22] and for the SOCS3 interactor p65 [22]. To date,
SOCS1 and SOCS3 are the only SOCS protein shown
to participitate in the ubiquitination and degradation of
proteins.2. Materials and Methods
2.1. Proteins used in the study
The Swiss-Prot entries for the proteins used in the study are: SOCS6
(Q95LY0), haem-oxidized IRP2 ubiquitin ligase-1 (HOIL-1; Q86SL2).
2.2. Yeast two-hybrid screen
Yeast strain L40 were transformed by with full-length murine socs6
cDNA cloned into the pBTM116 vector, and a human leukocyte
cDNA library fused in frame to GAL4 transcription activation domain
(MATCHMAKER Clontec). 107 transformants were selected on SD
medium lacking histidine, uracile, tryptophan and leucine, supple-
mented with 20 mM of 3-amino-1,2,4-triazole (Sigma), and incubated
for 3–5 days at 30 C. The selected clones were then assayed for b-
galactosidase activity. The double positive clones (His+, b-gal+) were
isolated and tested individually against either socs6 cDNA or negative
controls. For b-gal staining yeast colonies were grown at 30 C for 2
days on dishes, then transferred to nitrocellulose ﬁlters and frozen in
liquid nitrogen. Filters were placed on Whatman 3 MM papers that
had been soaked in Z buﬀer (60 mM Na2HPO4, 40 mM NaH2PO4,
10 mM KCl, 1 mM MgSO4 and 500 lg/mL X-gal) and incubated at
30 C.
2.3. Cell culture
COS-7 cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal calf serum, 100 U of penicillin/ml, 100 lg
of streptomycin/ml and 0.5 mg/mL sodium pyruvate. All media and
sera were purchased from Invitrogen. Cycloheximide, an inhibitor of
protein synthesis, and inhibitors of the proteasome, were purchased
from Sigma and Calbiochem, respectively.
2.4. Plasmids
SOCS6 full-length cDNA (nucleotides 217–1810), SOCS6 DNT
cDNA (nucleotides 1129–1810), SOCS6 SH2 cDNA (nucleotides
1129–1644), SOCS6 NT cDNA (nucleotides 217–1341), SOCS6 CT
cDNA (nucleotides 1621–1810), CIS cDNA coding for SH2 domainblished by Elsevier B.V. All rights reserved.
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cDNA (nucleotides 130–769), full-length SOCS2 cDNA (nucleotides
223–819), full-length SOCS4 cDNA (nucleotides 1–1311), full-length
SOCS5 cDNA (nucleotides 1–1611) and the entire cytoplasmic do-
main of wild-type murine KIT were subcloned in the pBTM116
yeast expression vector using the Gateway system (Invitrogen).
SOCS6 full-length cDNA and Elongin C full-length cDNA were
cloned in the vector pACT2. pEF-FLAG-SOCS6 construct was
kindly provided by D. Hilton (WEHI, Australia). The HA or
Myc-tagged HOIL-1 expression vector (pcDNA3.1) and HOIL-1
mutant constructs subcloned into the pGADT7 have been described
[24].2.5. Transfection procedure
Transfection of COS-7 cells was carried out in 60 mm plates. Cells
were transfected with FuGENE6 (Roche Applied Science) as recom-
mended by the manufacturer’s instructions with 0.2–1 lg of expression
vector. Where indicated, 10 lg/ml of MG132 or 50 lg/ml of cyclohex-
imide were added before cell lysis.2.6. Immunoprecipitation and Western blot analysis
Cells were washed in ice-cold phosphate-buﬀered saline prior to ly-
sis, and lysed in HNTG buﬀer (50 mM HEPES, pH 7, 50 mM NaF,
1 mM EGTA, 150 mM NaCl, 1% Triton X-100, 10% glycerol,
1.5 mM MgCl2) containing protease inhibitor cocktail (Roche Ap-
plied Science) and 100 lM Na3VO4. Clariﬁed cell lysates were mixed
for 16 h at 4 C with 1 lg of antibodies (anti-FLAG M2 monoclonal
antibody purchased from SIGMA, anti-SOCS6 rabbit antiserum
from Santa Cruz Biotechnology (sc-5608), anti-HA monoclonal anti-
body, clone3F10 from Roche Diagnostics) and a bed volume of 10 ll
of protein A or protein G sepharose 4 fast ﬂow (Amersham) for
immunoprecipitation. Following gel electrophoresis proteins were
transfered to Immobilon-P membranes (Millipore). Anti-FLAG M2
monoclonal antibody, anti-HA tag polyclonal antibody (Upstate Bio-
technology; 07–221), anti-HA tag monoclonal antibody (clone
12CA5, Roche Applied Science), and anti-Myc monoclonal antibody
(clone 9E10, Upstate Biotechnology) were used for immunoblotting.
Anti-p85 polyclonal rabbit was used as a loading control (Upstate
Biotechnology).3. Results
3.1. Screening for binding partners of SOCS6
To gain insight into the function of SOCS6, we screened a
human leukocyte cDNA library in the yeast two-hybrid system
with full-length socs6 cDNA as bait. Six independent clones
that activated both reporter genes when co-expressed with
SOCS6 but not with the Gal4 control were isolated. One of
the identiﬁed genes corresponded to the whole coding sequence
of HOIL-1 protein. The isolated HOIL-1 clone interacts with
SOCS6 but not with other SOCS proteins, CIS, SOCS1,
SOCS2, SOCS4 and SOCS5 (Fig. 1A). As controls, all SOCS
interacted with the Socs-box binding protein Elongin C and
did not show interaction with the Gal4 negative control
(Fig. 1A).3.2. SOCS6 interacts with HOIL-1 in cultured cells
To conﬁrm the interaction between HOIL-1 and SOCS6 in
mammalian cells, plasmids encoding Flag-tagged SOCS6 and
HA-tagged HOIL-1 cDNA were transfected in COS-7 cells.
Total cell lysates were subjected to co-immunoprecipitations.
As shown in Fig. 1B lane 4, SOCS6 was detected in HOIL-1
immunoprecipitate and conversely HOIL-1 was detected in
the SOCS6 immunoprecipitate. Controls without HOIL-1 or
without SOCS6 validated the interaction speciﬁcity.3.3. SOCS6 binds to the Ubl domain of HOIL-1 through the
SH2 domain and Socs-box
To map the domains of SOCS6 and HOIL-1 required for
the interaction, we used deletion and point mutants of both
proteins in the yeast two-hybrid system. pACT2-full length
HOIL-1 was transformed in yeast with various deletion
mutants of SOCS6 (Fig. 1C). SOCS6 mutant lacking the
NH2-terminal region-containing the SH2 domain and Socs-
box-bound to HOIL-1 (Fig. 1C). By contrast the SH2 do-
main only or the Socs-box alone, which interact with KIT
receptor and Elongin C, respectively (not shown), did not
interact with HOIL-1. These results show that the SH2 do-
main and the Socs-box of SOCS6 are required for the associ-
ation to HOIL-1. To conﬁrm this result, GST pulldown
experiments were done using cell lysates from COS-7 cells
transfected with a HOIL-1 expression vector. GST-SOCS6
SH2 domain and Socs-box, but not GST-SOCS6 NH2-termi-
nal region or GST-b-catenin control interacted with HOIL-1
(data not shown).
We next used deletion mutants of HOIL-1 to deﬁne the re-
gion required for the association with SOCS6. As shown in
Fig. 1D, HOIL-1 mutant lacking the Ubl domain (HOIL-
1D2888) failed to bind full-length SOCS6, whereas deletions
or point mutants of the RING ﬁnger region (HOIL-
1D240283 and HOIL-1C240,243S) interacted with SOCS6. Fur-
thermore, the Ubl domain alone (residues 1–88) was suﬃcient
for binding to SOCS6. These results indicate that the Ubl do-
main of HOIL-1 is necessary and suﬃcient for the interaction
with SOCS6. Using COS-7 cells and expression vectors for
HOIL-1 mutants we conﬁrmed that HOIL-1C240,243S mutant
interacts with SOCS6 while HOIL-1D2888does not (Fig. 1E,
lanes 4 and 6). In conclusion, SOCS6 protein interacts with
the Ubl domain of HOIL-1 through its SH2 domain and
Socs-box.3.4. HOIL-1 increases SOCS6 protein stability
A previous study has suggested that SOCS6 protein under-
goes a rapid turnover [23]. We conﬁrmed this observation in
COS-7 cells transiently transfected with a SOCS6 expression
vector (Fig. 2A, lanes 5–8). The expression level of SOCS6
protein was evaluated in cell lysates at diﬀerent time points
after treatment of the cells with cycloheximide. We also
examined the eﬀect of MG132 and Epoxomicin, two inhibi-
tors of the proteasome activity, on the stability of SOCS6
protein. SOCS6 protein was stabilized in cells treated with
MG132 (Fig. 2A, lanes 1–4), or Epoxomicin (Fig. 2B, lanes
1–4) indicating that SOCS6 is rapidly degraded by the protea-
some.
In the course of our study, we observed in some experiments
that the level of SOCS6 protein was increased in the presence
of HOIL-1. To examine whether the increased steady state le-
vel was due to increased stability of the protein, COS-7 cells
were transfected with SOCS6 with or without HOIL-1 and
the stability of SOCS6 protein was evaluated as described
above. In the absence of HOIL-1, the level of SOCS6 protein
rapidly decreased with an estimated half-life of 30 min
(Fig. 3, left panels). By contrast in the presence of HOIL-1,
SOCS6 half-life was increased to more than 1 h, suggesting
that HOIL-1 protein stabilizes SOCS6 protein (Fig. 3 right
panels).
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Fig. 1. Interaction of HOIL-1 with SOCS6 protein. (A) SOCS6 interacts with HOIL-1 in the yeast two-hybrid system. SOCS proteins, expressed as
LexA fusions in the pBTM116 plasmid, and HOIL-1 or Elongin C expressed as Gal4 fusion proteins in pACT2, were transformed in the yeast strain
L40. Interactions were revealed through staining for b-galactosidase activity with 5-bromo-1-chloro-3-indolyl-b-D-galactopyranoside (X-gal). (B) In
vivo interaction between SOCS6 and HOIL-1. Lysates from COS-7 cells transfected with pEF-Flag-SOCS6 and pcDNA3.1-HA-HOIL-1 as
indicated, were subjected to immunoprecipitation (IP) using either anti-HA 3F10 (Roche) or anti-SOCS6 antibodies (Santa-Cruz). Blots were then
probed (WB) with anti-HA (12CA5) or anti-Flag (M2) antibodies. Total cell lysates were analysed by Western blotting to control protein expression.
(C) HOIL-1 interacts with the SH2 and Socs-box domains of SOCS6. Various truncation mutants of SOCS6, expressed in the pBTM116 vector are
represented schematically. The amino acids expressed in the constructs are indicated. Interactions were assessed in the yeast two-hybrid system as in
(A). SH2, SH2 domain; SB, Socs-box. (D) The Ubl domain is necessary and suﬃcient to interact with SOCS6. LexA-SOCS6 and GAL4-HOIL-1
proteins were expressed in yeast L40 and the interaction was visualized using the HIS reporter gene. Yeast were plated in media lacking Trp and Leu
to select for plasmids expression, and in media lacking His to detect the interactions. (+) indicates growth in media lacking His. All yeast grew in
media lacking Trp and Leu. (E) COS-7 cells were transfected with pEF-Flag-SOCS6 and pcDNA3.1-HA-HOIL-1 or HOIL-1D2888 mutant or HOIL-
1C240,243S mutant as indicated, lysed and subjected to immunoprecipitation (IP) using anti-SOCS6 polyclonal antibodies. Following Western blotting,
membranes were probed with anti-HA 12CA5.
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Fig. 2. SOCS6 protein is rapidly degraded by the proteasome. COS-7
cells were transfected with pEF-Flag-SOCS6 plasmid. Twenty four
hours later, the cells were then treated with 50 lg/ml cycloheximide for
the indicated time with or without 10 lg/ml MG132 (A) or 2 lM
Epoxomicin (B). Total cell lysates were analysed by Western blotting
with anti-Flag antibody to detect SOCS6. To control for equivalent
loading in each lane, the membranes were stripped and reprobed to
detect STAT5b or ERK2.
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Fig. 3. HOIL-1 increases the stability of SOCS6 protein. COS-7 cells
were transfected with pEF-Flag-SOCS6 and pcDNA3.1-HA-HOIL-1.
Cells were treated 24 h post transfection with 50 lg/ml cycloheximide
for diﬀerent time points. Total cell lysates were analysed by Western
blotting. Membranes were probed with anti-Flag (M2), anti-Myc
(clone 9E10) or anti-p85 to detect SOCS6, HOIL-1 and p85 proteins,
respectively.
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proteins
To investigate the biological consequence of the interaction
between SOCS6 and HOIL-1, COS-7 cells were transfectedA
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Fig. 4. HOIL-1 promotes the ubiquitination of SOCS6 associated proteins. (A
Myc-HOIL-1 expression plasmids as indicated. Equivalent amounts of ly
antibodies. Coimmunoprecipitations and total cell lysates were analysed by
corresponding to lane 3 of (A) were immunoprecipitated with anti-Flag anti
protein interactions. (C) COS-7 cells transfected with Flag-SOCS6, HA-ubiq
before lysis and immunoprecipitation with anti-SOCS6 antibodies. The expos
(A) and (B).with Flag-tagged SOCS6 and HA-tagged ubiquitin in the pres-
ence or absence of HOIL-1. Ubiquitin-tagged proteins were
detected in SOCS6 immunoprecipitate only in the presence
of HOIL-1 (Fig. 4A, lane 3). The smear of protein ubiquitina-
tion was not seen with the Ubl deleted HOIL-1 mutant (not
shown). To determine if these proteins represented polyubiqui-
tinated forms of SOCS6 or other proteins associated to
SOCS6, the lysates where boiled before immunoprecipitation
to disrupt protein interactions. In these conditions the amount
of polyubiquitinated proteins associated to SOCS6 is severely
decreased (Fig. 4B). This result suggests that SOCS6 associ-
ated proteins rather than SOCS6 itself represent the bulk of
of the ubiquitinated proteins in SOCS6 immunoprecipitates.
Furthermore, the ubiquitination signal is increased when cells
were treated with a proteasome inhibitor (Fig. 4C), indicating
that the ubiquitin-tagged proteins are substrates for the
proteasome.LIOH-cyM 1
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) COS-7 cells were cotransfected with Flag-SOCS6, HA-ubiquitin, and
sates were immunoprecipitated either with anti-SOCS6 or anti-HA
western blotting with the indicated antibodies. (B) Lysates from cells
body, either directly or after incubation at 100 C for 5 min to disrupt
uitin, and Myc-HOIL-1 were either untreated or treated with MG132
ure of the western blot shown in (C) is deliberately shorter compared to
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In this report, we present evidence that E3 ubiquitin ligase
HOIL-1 speciﬁcally binds to SOCS6. We could not however
test the endogenous interaction because of the lack of re-
agents that recognize the endogenous proteins. HOIL-1
was cloned as the E3 ligase that recognizes oxidized IRP2
causing its degradation through the ubiquitin machinery
[24]. It also binds to hepatitis B virus X protein [25], PKC
[26] and the E2 ubiquitin conjugating enzyme UbcM4 [27].
We show here that binding of HOIL-1 to SOCS6 requires
the SH2 domain and the Socs-box of SOCS6 and the Ubl
domain of HOIL-1. Furthermore, HOIL-1 delays SOCS6
protein degradation and induces the ubiquitination of pro-
teins associated to SOCS6.
In our experiments we found that SOCS6 has a short half-
life. Previous studies indicated that SOCS proteins, namely
CIS, SOCS1, SOCS2, SOCS3 and SOCS6, are very short-lived
proteins [28]. SOCS3 and SOCS6 proteins are stabilized in the
presence of proteasome inhibitors, indicating that the level of
expression of these proteins is controlled by the proteasome
([23,29,30] our study).
The half-life of SOCS proteins have been shown to be regu-
lated both by protein–protein interaction and phosphorylation.
Several reports have suggested that the interaction of SOCS
box with Elongin BC complex stabilizes SOCS1 by inhibiting
proteasome-mediated degradation [31–33]. By contrast, the
RING-ﬁnger containing protein TRIM8/GERP interacts with
SOCS1 and decreases its stability [34]. Similar to HOIL-1/
SOCS6 association, both the SH2 and the Socs-box domains
are required for the interaction of TRIM8 with SOCS1. The
reason for the dual domain requirement remains to be eluci-
dated. Whether the function of TRIM8 is to regulate SOCS1
expression or target SOCS1 partners is still unclear. Serine/thre-
onine kinases Pim1 and Pim2 interact with, phosphorylate
SOCS1 and increase SOCS1 protein stability. By contrast
SOCS3 phosphorylation at two positions on tyrosine residues
correlates with decreased stability and loss of Elongin C bind-
ing [35]. We show here that the Ring-ﬁnger protein HOIL-1 sta-
bilizes SOCS6 expression by preventing proteasome-mediated
protein degradation. This suggests that HOIL-1 prevents bind-
ing of a protein responsible for SOCS6 degradation or alters
SOCS6 re-localization to the proteasome machinery. However,
the protection provided by HOIL-1 is transient: HOIL-1 delays
but does not abolish the degradation of SOCS6 (as illustrated
Fig. 3, lane 8). Therefore, it is likely that other mechanisms con-
tribute to the stability of SOCS6 protein.
In this report, we present evidence that proteins associated
with SOCS6 are polyubiquitinated and degraded through the
proteasome. This is consistent with the hypothesis that postu-
lates that SOCS proteins act as adaptor proteins to recruit sub-
strates to the ubiquitination machinery. Previous data in
favour of this model included regulation by SOCS1 of VAV
[20], JAK2 [17] TEL-JAK2 [18,19], IRS1, IRS2 [21], p65REL
[22] and FAK [36]. Liu et al. have also shown evidence for a
role of SOCS3 in FAK regulation [36]. Hence, SOCS6 is the
third member of the SOCS family demonstrated to display
substrate adaptor function as part of an E3 ligase complex.
Socs-box containing proteins, including all eight SOCS pro-
teins interact with Elongin BC, a component of an E3 ligase
multiprotein complex. Interestingly, SOCS1 interacts with
TRIM8 a putative E3 ubiquitin ligase [36]. This observation,together with our ﬁnding that HOIL-1 speciﬁcally interacts
with SOCS6, and the fact that such interactions with E3 ligases
inﬂuences the half-life of SOCS proteins, suggests additional
levels of complexity in the ubiquitination function of SOCS
family proteins. We propose that each SOCS protein may
associate with at least a second E3 ligase in addition to the
Elongin BC/Cullin E3 complex. The substrate adaptor func-
tion of SOCS proteins would then depend on the composition
of associated multiproteins complexes. The search for addi-
tional E3 ligases associated with SOCS proteins as well as
the systematic description of proteins that interact with each
member of the SOCS family should shed light on mechanism
of action and the function of SOCS proteins.
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